Nucleophosmin (NPM1/B23) interacts with activating transcription factor 5 (ATF5) protein and promotes proteasome- and caspase-dependent ATF5 degradation in hepatocellular carcinoma cells. 2012

Xijun Liu, and Dan Liu, and Dongmeng Qian, and Jenny Dai, and Yi An, and Shaoyan Jiang, and Bruce Stanley, and Jinming Yang, and Bin Wang, and Xinyuan Liu, and David X Liu
Penn State College of Medicine, Hershey, Pennsylvania 17033, USA.

Nucleophosmin (NPM1/B23) and the activating transcription factor 5 (ATF5) are both known to subject to cell type-dependent regulation. NPM1 is expressed weakly in hepatocytes and highly expressed in hepatocellular carcinomas (HCC) with a clear correlation between enhanced NPM1 expression and increased tumor grading and poor prognosis, whereas in contrast, ATF5 is expressed abundantly in hepatocytes and down-regulated in HCC. Re-expression of ATF5 in HCC inhibits cell proliferation. We report here that using an unbiased approach, tandem affinity purification (TAP) followed with mass spectrometry (MS), we identified NPM1 as a novel ATF5-interacting protein. Unlike many other NPM1-interacting proteins that interact with the N-terminal oligomerization domain of NPM1, ATF5 binds via its basic leucine zipper to the C-terminal region of NPM1 where its nucleolar localization signal is located. NPM1 association with ATF5, whose staining patterns partially overlap in the nucleoli, promotes ATF5 protein degradation through proteasome-dependent and caspase-dependent pathways. NPM1-c, a mutant NPM1 that is defective in nucleolar localization, failed to stimulate ATF5 polyubiquitination and was unable to down-regulate ATF5. NPM1 interaction with ATF5 displaces HSP70, a known ATF5-interacting protein, from ATF5 protein complexes and antagonizes its role in stabilization of ATF5 protein. NPM1-promoted ATF5 down-regulation diminished ATF5-mediated repression of cAMP-responsive element-dependent gene transcription and abrogates ATF5-induced G(2)/M cell cycle blockade and inhibition of cell proliferation in HCC cells. Our study establishes a mechanistic link between elevated NPM1 expression and depressed ATF5 in HCC and suggests that regulation of ATF5 by NPM1 plays an important role in the proliferation and survival of HCC.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D009687 Nuclear Proteins Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus. Nucleolar Protein,Nucleolar Proteins,Nuclear Protein,Protein, Nuclear,Protein, Nucleolar,Proteins, Nuclear,Proteins, Nucleolar
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000090243 Nucleophosmin Predominantly localized in the CELL NUCLEOLUS, involved in diverse cellular processes such as ribosome biogenesis, cytoplasmic-nuclear trafficking, centrosome duplication, and regulation of p53. NO38 Protein,Nucleolar Phosphoprotein B23,Nucleolar Protein B23,Nucleophosmid,Numatrin,Phosphoprotein B23, Nucleolus,Protein B23,B23, Nucleolar Phosphoprotein,B23, Nucleolar Protein,B23, Nucleolus Phosphoprotein,B23, Protein,Nucleolus Phosphoprotein B23,Phosphoprotein B23, Nucleolar,Protein B23, Nucleolar,Protein, NO38
D015972 Gene Expression Regulation, Neoplastic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. Neoplastic Gene Expression Regulation,Regulation of Gene Expression, Neoplastic,Regulation, Gene Expression, Neoplastic
D046988 Proteasome Endopeptidase Complex A large multisubunit complex that plays an important role in the degradation of most of the cytosolic and nuclear proteins in eukaryotic cells. It contains a 700-kDa catalytic sub-complex and two 700-kDa regulatory sub-complexes. The complex digests ubiquitinated proteins and protein activated via ornithine decarboxylase antizyme. 20S Proteasome,Ingensin,Macropain,Macroxyproteinase,Multicatalytic Endopeptidase Complex,Multicatalytic Proteinase,Prosome,Proteasome,Complex, Multicatalytic Endopeptidase,Complex, Proteasome Endopeptidase,Endopeptidase Complex, Multicatalytic,Endopeptidase Complex, Proteasome,Proteasome, 20S,Proteinase, Multicatalytic
D051696 Activating Transcription Factors Activating transcription factors were originally identified as DNA-BINDING PROTEINS that interact with early promoters from ADENOVIRUSES. They are a family of basic leucine zipper transcription factors that bind to the consensus site TGACGTCA of the cyclic AMP response element, and are closely related to CYCLIC AMP-RESPONSIVE DNA-BINDING PROTEIN. ATF Transcription Factors,Factors, ATF Transcription,Transcription Factors, ATF

Related Publications

Xijun Liu, and Dan Liu, and Dongmeng Qian, and Jenny Dai, and Yi An, and Shaoyan Jiang, and Bruce Stanley, and Jinming Yang, and Bin Wang, and Xinyuan Liu, and David X Liu
August 2012, The FEBS journal,
Xijun Liu, and Dan Liu, and Dongmeng Qian, and Jenny Dai, and Yi An, and Shaoyan Jiang, and Bruce Stanley, and Jinming Yang, and Bin Wang, and Xinyuan Liu, and David X Liu
July 2006, Zhonghua bing li xue za zhi = Chinese journal of pathology,
Xijun Liu, and Dan Liu, and Dongmeng Qian, and Jenny Dai, and Yi An, and Shaoyan Jiang, and Bruce Stanley, and Jinming Yang, and Bin Wang, and Xinyuan Liu, and David X Liu
March 2014, The Journal of biological chemistry,
Xijun Liu, and Dan Liu, and Dongmeng Qian, and Jenny Dai, and Yi An, and Shaoyan Jiang, and Bruce Stanley, and Jinming Yang, and Bin Wang, and Xinyuan Liu, and David X Liu
February 2005, The Journal of biological chemistry,
Xijun Liu, and Dan Liu, and Dongmeng Qian, and Jenny Dai, and Yi An, and Shaoyan Jiang, and Bruce Stanley, and Jinming Yang, and Bin Wang, and Xinyuan Liu, and David X Liu
February 2018, Virology,
Xijun Liu, and Dan Liu, and Dongmeng Qian, and Jenny Dai, and Yi An, and Shaoyan Jiang, and Bruce Stanley, and Jinming Yang, and Bin Wang, and Xinyuan Liu, and David X Liu
February 2007, British journal of cancer,
Xijun Liu, and Dan Liu, and Dongmeng Qian, and Jenny Dai, and Yi An, and Shaoyan Jiang, and Bruce Stanley, and Jinming Yang, and Bin Wang, and Xinyuan Liu, and David X Liu
November 2017, Journal of proteome research,
Xijun Liu, and Dan Liu, and Dongmeng Qian, and Jenny Dai, and Yi An, and Shaoyan Jiang, and Bruce Stanley, and Jinming Yang, and Bin Wang, and Xinyuan Liu, and David X Liu
January 2023, American journal of cancer research,
Xijun Liu, and Dan Liu, and Dongmeng Qian, and Jenny Dai, and Yi An, and Shaoyan Jiang, and Bruce Stanley, and Jinming Yang, and Bin Wang, and Xinyuan Liu, and David X Liu
June 2018, Molecular medicine reports,
Xijun Liu, and Dan Liu, and Dongmeng Qian, and Jenny Dai, and Yi An, and Shaoyan Jiang, and Bruce Stanley, and Jinming Yang, and Bin Wang, and Xinyuan Liu, and David X Liu
August 2013, Molecular biology of the cell,
Copied contents to your clipboard!